These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 15115632

  • 1. Vaccination strategies to prevent genital herpes and neonatal herpes simplex virus (HSV) disease.
    Jones CA, Cunningham AL.
    Herpes; 2004 Apr; 11(1):12-7. PubMed ID: 15115632
    [Abstract] [Full Text] [Related]

  • 2. Development of prophylactic vaccines for genital and neonatal herpes.
    Jones CA, Cunningham AL.
    Expert Rev Vaccines; 2003 Aug; 2(4):541-9. PubMed ID: 14711338
    [Abstract] [Full Text] [Related]

  • 3. Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection.
    Da Costa XJ, Morrison LA, Knipe DM.
    Virology; 2001 Sep 30; 288(2):256-63. PubMed ID: 11601897
    [Abstract] [Full Text] [Related]

  • 4. Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs.
    Bourne N, Bravo FJ, Francotte M, Bernstein DI, Myers MG, Slaoui M, Stanberry LR.
    J Infect Dis; 2003 Feb 15; 187(4):542-9. PubMed ID: 12599070
    [Abstract] [Full Text] [Related]

  • 5. Glycoprotein-D-adjuvant vaccine to prevent genital herpes.
    Stanberry LR, Spruance SL, Cunningham AL, Bernstein DI, Mindel A, Sacks S, Tyring S, Aoki FY, Slaoui M, Denis M, Vandepapeliere P, Dubin G, GlaxoSmithKline Herpes Vaccine Efficacy Study Group.
    N Engl J Med; 2002 Nov 21; 347(21):1652-61. PubMed ID: 12444179
    [Abstract] [Full Text] [Related]

  • 6. Clinical trials of prophylactic and therapeutic herpes simplex virus vaccines.
    Stanberry LR.
    Herpes; 2004 Aug 21; 11 Suppl 3():161A-169A. PubMed ID: 15319086
    [Abstract] [Full Text] [Related]

  • 7. [Herpes simplex virus vaccine studies: from past to present].
    Us D.
    Mikrobiyol Bul; 2006 Oct 21; 40(4):413-33. PubMed ID: 17205702
    [Abstract] [Full Text] [Related]

  • 8. Limited antibody-dependent cellular cytotoxicity antibody response induced by a herpes simplex virus type 2 subunit vaccine.
    Kohl S, Charlebois ED, Sigouroudinia M, Goldbeck C, Hartog K, Sekulovich RE, Langenberg AG, Burke RL.
    J Infect Dis; 2000 Jan 21; 181(1):335-9. PubMed ID: 10608784
    [Abstract] [Full Text] [Related]

  • 9. Vaccines for herpes simplex virus infections.
    Koelle DM.
    Curr Opin Investig Drugs; 2006 Feb 21; 7(2):136-41. PubMed ID: 16499283
    [Abstract] [Full Text] [Related]

  • 10. Enhancement of protective humoral immune responses against Herpes simplex virus-2 in DNA-immunized guinea-pigs using protein boosting.
    Fotouhi F, Soleimanjahi H, Roostaee MH, Behzadian F.
    FEMS Immunol Med Microbiol; 2008 Oct 21; 54(1):18-26. PubMed ID: 18647350
    [Abstract] [Full Text] [Related]

  • 11. Comparison of intramuscular and footpad subcutaneous immunization with DNA vaccine encoding HSV-gD2 in mice.
    Jazayeri M, Soleimanjahi H, Fotouhi F, Pakravan N.
    Comp Immunol Microbiol Infect Dis; 2009 Sep 21; 32(5):453-61. PubMed ID: 18571235
    [Abstract] [Full Text] [Related]

  • 12. A recombinant multivalent combination vaccine protects against Chlamydia and genital herpes.
    Macmillan L, Ifere GO, He Q, Igietseme JU, Kellar KL, Okenu DM, Eko FO.
    FEMS Immunol Med Microbiol; 2007 Feb 21; 49(1):46-55. PubMed ID: 17094789
    [Abstract] [Full Text] [Related]

  • 13. Protection from herpes simplex virus (HSV)-2 infection with replication-defective HSV-2 or glycoprotein D2 vaccines in HSV-1-seropositive and HSV-1-seronegative guinea pigs.
    Hoshino Y, Pesnicak L, Dowdell KC, Burbelo PD, Knipe DM, Straus SE, Cohen JI.
    J Infect Dis; 2009 Oct 01; 200(7):1088-95. PubMed ID: 19702506
    [Abstract] [Full Text] [Related]

  • 14. Effect of maternal herpes simplex virus (HSV) serostatus and HSV type on risk of neonatal herpes.
    Brown EL, Gardella C, Malm G, Prober CG, Forsgren M, Krantz EM, Arvin AM, Yasukawa LL, Mohan K, Brown Z, Corey L, Wald A.
    Acta Obstet Gynecol Scand; 2007 Oct 01; 86(5):523-9. PubMed ID: 17464578
    [Abstract] [Full Text] [Related]

  • 15. Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial.
    Scott LL, Hollier LM, McIntire D, Sanchez PJ, Jackson GL, Wendel GD.
    Infect Dis Obstet Gynecol; 2001 Oct 01; 9(2):75-80. PubMed ID: 11495557
    [Abstract] [Full Text] [Related]

  • 16. Ocular herpes simplex: changing epidemiology, emerging disease patterns, and the potential of vaccine prevention and therapy.
    Pepose JS, Keadle TL, Morrison LA.
    Am J Ophthalmol; 2006 Mar 01; 141(3):547-557. PubMed ID: 16490506
    [Abstract] [Full Text] [Related]

  • 17. Valacyclovir prophylaxis to prevent recurrent herpes at delivery: a randomized clinical trial.
    Sheffield JS, Hill JB, Hollier LM, Laibl VR, Roberts SW, Sanchez PJ, Wendel GD.
    Obstet Gynecol; 2006 Jul 01; 108(1):141-7. PubMed ID: 16816068
    [Abstract] [Full Text] [Related]

  • 18. Maternal immunization with a herpes simplex virus type 2 replication-defective virus reduces visceral dissemination but not lethal encephalitis in newborn mice after oral challenge.
    Evans IA, Jones CA.
    J Infect Dis; 2002 Jun 01; 185(11):1550-60. PubMed ID: 12023760
    [Abstract] [Full Text] [Related]

  • 19. Impact of immunization with glycoprotein D2/AS04 on herpes simplex virus type 2 shedding into the genital tract in guinea pigs that become infected.
    Bourne N, Milligan GN, Stanberry LR, Stegall R, Pyles RB.
    J Infect Dis; 2005 Dec 15; 192(12):2117-23. PubMed ID: 16288376
    [Abstract] [Full Text] [Related]

  • 20. Type-specific screening for asymptomatic herpes infection in pregnancy: a decision analysis.
    Cleary KL, Paré E, Stamilio D, Macones GA.
    BJOG; 2005 Jun 15; 112(6):731-6. PubMed ID: 15924528
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.